A randomised trial of intravesical thiotepa versus no intravesical chemotherapy

Completed

• Conditions: Cancer; Bladder cancer

• Registration Number: ISRCTN57776460
• Lead Sponsor: Medical Research Council (MRC) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2001-03-13
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 417

Inclusion Criteria

1. Newly diagnosed superficial carcinoma of the bladder suitable for complete endoscopic resection
2. World Health Organisation (WHO) performance status 0-2
3. Expected survival at least 3 years
4. White count >3 x 10^9/L and platelets >100 x 10^9/L
5. No history of other malignant tumours
6. No untreated urinary tract infection

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Time to first superficial<br>2. Recurrence rate (number of positive cytoscopies per annum) <br>3. Failure-free survival rate

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration